<DOC>
	<DOC>NCT00363337</DOC>
	<brief_summary>The specific aim of this study is to obtain preliminary evidence of the acute effectiveness and tolerability of aripiprazole in the treatment of bipolar depression.</brief_summary>
	<brief_title>A Preliminary Study of the Effectiveness and Tolerability of Aripiprazole in Bipolar Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>subjects must have bipolar I, II or NOS disorder as defined by DSMIVTR; must have clinical significant depressive symptoms and have failed one or more mood stabilizer trials; may or may not be receiving antimanic or mood stabilizing medications; subjects or legally authorized representative must sign the Informed Consent document after the nature of the trial has been fully explained; if female, subjects must be postmenopausal, surgically incapable of childbearing or practicing medically acceptable effective method(s) of contraception. subjects who do not have bipolar disorder by DSMIV criteria; subjects with current DSMIV Axis I diagnosis of delirium, dementia, amnesia or other cognitive disorders or a psychotic disorder; subjects with serious general medical illness; subjects who are allergic to or have demonstrated hypersensitivity to aripiprazole; women who are pregnant or nursing; subjects who have received an experimental drug or used an experimental device within 30 days; subjects who have a history of neurologic malignant syndrome.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Adults</keyword>
	<keyword>Bipolar Depression</keyword>
	<keyword>Bipolar Disorder</keyword>
	<keyword>Bipolar I</keyword>
	<keyword>Bipolar II</keyword>
	<keyword>Depression</keyword>
</DOC>